Zinc Cold Lozenges Market Report 2025

The zinc cold lozenges market size has grown strongly in recent years. It will grow from $1.2 billion in 2024 to $1.29 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the increasing prevalence of common colds and respiratory infections, rising consumer preference for over-the-counter (OTC) remedies, growing awareness of zinc’s immune-boosting properties, increasing demand for natural and herbal cold relief products, and the rise of self-medication and preventive healthcare practices.

The zinc cold lozenges market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period is expected to be driven by increasing adoption of zinc lozenges for immune support, rising popularity of combinations with elderberry and vitamin C, growing availability of sugar-free and vegan formulations, increasing demand for travel-friendly and on-the-go health solutions, and a stronger focus on preventive healthcare and wellness. Major trends in the forecast period include advancements in zinc lozenge formulations with added functional ingredients, wider distribution through e-commerce platforms, innovations in convenient and sustainable packaging, development of personalized health solutions using AI and data analytics, and integration of wellness ecosystems combining supplements with lifestyle products.

The growing incidence of respiratory infections is expected to drive the expansion of the zinc cold lozenges market. Respiratory infections occur when harmful microorganisms invade and multiply in the respiratory tract, leading to illnesses such as colds, flu, or pneumonia. The rise in respiratory infections is largely due to increased air pollution, which weakens the respiratory system and makes individuals more prone to infections. Zinc cold lozenges help with respiratory infections by offering immune support and reducing the severity and duration of common cold symptoms. They provide an easy-to-use solution by soothing throat irritation and supporting the body’s defenses against infections. For example, in May 2025, the New York Academy of Sciences, a U.S.-based nonprofit organization, reported that whooping cough cases had exceeded 8,000, marking more than a twofold increase compared to the same period the previous year. Therefore, the rising incidence of respiratory infections is contributing to the growth of the zinc cold lozenges market.

The growth of e-commerce is expected to boost the zinc cold lozenges market in the coming years. E-commerce involves the buying and selling of goods and services over the internet. The growth of e-commerce is driven by increased internet access, which allows consumers to shop conveniently at any time and from anywhere. E-commerce benefits the zinc cold lozenges market by providing easy online access and broader availability, making it convenient for consumers who prefer quick purchasing options. It enhances market reach by facilitating direct-to-consumer sales, improving product accessibility and convenience for customers. For instance, in February 2025, the United States Census Bureau reported that total e-commerce sales reached $1.19 trillion in 2024, an 8.1% increase from 2023. As a result, the rise of e-commerce is driving the growth of the zinc cold lozenges market.

The increasing healthcare expenditure is expected to support the growth of the zinc cold lozenges market. Healthcare expenditure refers to the total spending on medical services, treatments, facilities, research, and public health programs aimed at improving health outcomes. The rise in healthcare spending is driven by the growing prevalence of chronic diseases, which require expensive and long-term treatments. As healthcare expenditure increases, consumer spending on preventive and over-the-counter healthcare products, including zinc cold lozenges, is rising. This trend makes zinc cold lozenges an attractive option for supporting immunity and managing minor respiratory infections. It also increases market adoption by providing broader access to affordable and effective cold relief solutions. For example, in May 2024, the Office for National Statistics in the UK reported a 5.6% increase in healthcare expenditure in 2023, a 0.9% rise compared to 2022. Thus, the growing healthcare expenditure is contributing to the growth of the zinc cold lozenges market.

Major players in the zinc cold lozenges market are Church & Dwight Co. Inc., Prestige Consumer Healthcare Inc., Quantum Health Inc., NOW Health Group Inc., Swanson Health Products Inc., Life Extension Foundation Buyers Club Inc., Nature’s Way Products LLC, Sydler Remedies Pvt. Ltd., Douglas Laboratories (Atrium Innovations Inc. Nestlé Health Science), Kharkhana Zinda Tilismath, Seeking Health LLC, DaVinci Laboratories of Vermont (FoodScience Corporation), Nutri-West Inc., Vespyr Brands LLC, Nutritional Frontiers LLC, Wiscon Pharmaceuticals Pvt. Ltd., Sitnez Biocare Pvt. Ltd., Prason Foods Private Limited, Wellona Pharma Pvt. Ltd., and Vaegi Nutra Private Limited.

North America was the largest region in the zinc cold lozenges market in 2024. The regions covered in zinc cold lozenges report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the zinc cold lozenges market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

Zinc cold lozenges are medicated tablets that dissolve in the mouth, releasing zinc which may help shorten the duration and lessen the severity of common cold symptoms such as sore throat, cough, and nasal congestion. They are commonly used as over-the-counter remedies to support immune function and relieve cold-related discomfort.

The primary product types of zinc cold lozenges include sugar-free zinc lozenges, flavored zinc lozenges, herbal zinc lozenges, and others. Sugar-free zinc lozenges provide the benefits of zinc for alleviating cold and flu symptoms without added sugars, making them suitable for health-conscious consumers and those with dietary restrictions. These lozenges come in various forms, including tablets, gummies, hard lozenges, and others, and are distributed through pharmacies, supermarkets, online retailers, and other channels. They are used for cold and flu relief, immune support, and related applications.

The zinc cold lozenges market research report is one of a series of new reports that provides zinc cold lozenges market statistics, including the zinc cold lozenges industry global market size, regional shares, competitors with the zinc cold lozenges market share, detailed zinc cold lozenges market segments, market trends, and opportunities, and any further data you may need to thrive in the zinc cold lozenges industry. This zinc cold lozenges market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The zinc cold lozenges market includes of sales of rapidmelts, throat sprays, and medicated fruit drops. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.